HPV-SAVE and PEACH studies: An update on Canadian studies examining anal cancer
Learning Series
Troy Grennan, MD MSc FRCPC DTM&H Physician Lead, HIV/STI Program – Clinical Prevention Services BC Centre for Disease Control Clinical Assistant Professor, Division of Infectious Diseases, University of British Columbia
The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025